Lion Biotechnologies Announces Exclusive License Agreement With Moffitt Cancer Center Read more about Lion Biotechnologies Announces Exclusive License Agreement With Moffitt Cancer Center
Lion Biotechnologies Enters Clinical Trial Grant Agreement With Moffitt Cancer Center Read more about Lion Biotechnologies Enters Clinical Trial Grant Agreement With Moffitt Cancer Center
Lion Biotechnologies' Chief Scientific Officer to Present at Immunotherapies and Vaccines Summit Read more about Lion Biotechnologies' Chief Scientific Officer to Present at Immunotherapies and Vaccines Summit
Lion Biotechnologies Names Elma Hawkins President and Chief Operating Officer Read more about Lion Biotechnologies Names Elma Hawkins President and Chief Operating Officer
Lion Biotechnologies to Present at the Rodman & Renshaw 16th Annual Global Investment Conference Read more about Lion Biotechnologies to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
Lion Biotechnologies CSO Laszlo Radvanyi Co-Authors Study in Journal of Immunotherapy Read more about Lion Biotechnologies CSO Laszlo Radvanyi Co-Authors Study in Journal of Immunotherapy
Lion Biotechnologies Announces Management Change Read more about Lion Biotechnologies Announces Management Change
Lion Biotechnologies Announces Clinical Data Update at American Society of Hematology Annual Meeting Read more about Lion Biotechnologies Announces Clinical Data Update at American Society of Hematology Annual Meeting
Lion Biotechnologies to Present at the Piper Jaffray 26th Annual Healthcare Conference Read more about Lion Biotechnologies to Present at the Piper Jaffray 26th Annual Healthcare Conference
Lion Biotechnologies Names Elma Hawkins President, Chief Executive Officer and Director Read more about Lion Biotechnologies Names Elma Hawkins President, Chief Executive Officer and Director